5 Star Review

"Most helpful, steered us in the right direction for treatmen...." see more

Elaine C. - Mesothelioma Patient

5 Star Review

"Because of their guidance, I was able to navigate getting my...." see more

Deanna B. - Daughter of a Mesothelioma Patient

5 Star Review

"Hearing the news about my mother's diagnosis was heartbreaki...." see more

Danielle W. - Daughter of a Mesothelioma Patient

5 Star Review

"My son Carlos was diagnosed with this terrible and unknown d...." see more

Martha M. - Mother of a Mesothelioma Patient

5 Star Review

"Extremely communicative and helped my dad get an appointment...." see more

Sunni H. - Loved One of a Mesothelioma Patient

5 Star Review

"Danielle DiPietro was an invaluable resource for me. Her sug...." see more

Deborah C. - Spouse of a Mesothelioma Patient

5 Star Review

"I was very grateful and appreciative of Dr. Smart from The M...." see more

Kimberlin C. - Spouse of a Mesothelioma Patient

5 Star Review

"In January of 2016, my husband was diagnosed with peritoneal...." see more

Gloria R. - Spouse of a Mesothelioma Patient

Expertise:
Lung Cancer
Immunotherapy
Speciality:
Medical Oncology
Gender:
Female
Language:
English, Japanese

Get to Know Dr. Misako Nagasaka

Dr. Misako Nagasaka plays a key role in the multidisciplinary treatment of thoracic and head-and-neck malignancies at UCI Health Chao Family Comprehensive Cancer Center.

With an unusual background that includes philosophy and ethics, Nagasaka is known for an ability to put patients at ease, fully educating them on their treatment options with her personalized approach.

She has more than a decade of experience in treating lung cancer and mesothelioma patients, exploring options that go well beyond standard chemotherapy.

Nagasaka’s research involves novel clinical trials that have advanced the treatment of lung cancer with various immunotherapy combinations. She works closely with surgical oncologists, radiologists and pathologists to individualize treatment for each patient.

She also serves as an associate professor of Hematology/Oncology at UCI School of Medicine.

Specialties of Dr. Misako Nagasaka

Dr. Misako Nagasaka’s Experience and Medical Education

  • UCI Health Chao Family Comprehensive Cancer Center
  • Barbara Ann Karmanos Cancer Institute
  • Beth Israel Medical Center in New York (Residency)
  • National Center for Global Health and Medicine, Tokyo (Residency)
  • Karmanos Cancer Institute (Hematology and oncology fellowships)
  • St. Marianna University School of Medicine, Japan

Awards and Other Recognitions

  • N Program Scholar Award, Tokio Marine Foundation
  • St. Marianna University Scholarship Award
  • American Society of Clinical Oncology (Member)
  • American College of Physicians (Member)
  • American Board of Internal Medicine (Member)

Publications of Dr. Misako Nagasaka

  • Nagasaka, M. et al. (2020, May 11). Mortality and risk of progression to adult T cell leukemia/lymphoma in HTLV-1–associated myelopathy/tropical spastic paraparesis. Proceedings of the National Academy of Sciences.
  • Nagasaka, M. et al. (2019, June 18). A retrospective study evaluating the pretreatment tumor volume (PTV) in non-small cell lung cancer (NSCLC) as a predictor of response to program death-1 (PD-1) inhibitors. Dovepress.
  • Abdallah, N. et al. (2018, July 17). Non-small cell to small cell lung cancer on PD-1 inhibitors: two cases on potential histologic transformation. Dovepress.